{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:07:50Z","timestamp":1773450470583,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"am","delay-in-days":395,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","award":["LUAUS24120"],"award-info":[{"award-number":["LUAUS24120"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"NICHD","doi-asserted-by":"publisher","award":["Z1AHD008735"],"award-info":[{"award-number":["Z1AHD008735"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.beem.2024.101941","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T16:51:44Z","timestamp":1726073504000},"page":"101941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of B cells in intratumoral MBTA immunotherapy of murine pheochromocytoma model"],"prefix":"10.1016","volume":"39","author":[{"given":"Ondrej","family":"Uher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Hadrava Vanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Petrlakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Labitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radka","family":"Lencova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Frejlachova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Masarik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Zenka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengping","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2024.101941_bib1","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnae005","article-title":"The immune landscape of pheochromocytoma and paraganglioma: current advances and perspectives","author":"Uher","year":"2024","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2024.101941_bib2","doi-asserted-by":"crossref","DOI":"10.1053\/j.seminoncol.2019.10.004","article-title":"Coley's immunotherapy revived: innate immunity as a link in priming cancer cells for an attack by adaptive immunity","author":"Uher","year":"2019","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.beem.2024.101941_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050654","article-title":"The significant reduction or complete eradication of subcutaneous and metastatic lesions in a pheochromocytoma mouse model after immunotherapy using Mannan-BAM, TLR ligands, and anti-CD40","volume":"11","author":"Caisova","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.beem.2024.101941_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.intimp.2018.03.038","article-title":"Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis","volume":"59","author":"Caisova","year":"2018","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"10.1016\/j.beem.2024.101941_bib5","article-title":"Induction of immune response against metastatic tumors via vaccination of Mannan-BAM, TLR ligands and anti-CD40 antibody (MBTA)","volume":"3","author":"Medina","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.beem.2024.101941_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1030412","article-title":"Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy","volume":"14","author":"Uher","year":"2023","journal-title":"Front Endocrinol"},{"issue":"16","key":"10.1016\/j.beem.2024.101941_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13163942","article-title":"Identification of immune cell infiltration in murine pheochromocytoma during combined Mannan-BAM, TLR ligand, and Anti-CD40 antibody-based immunotherapy","volume":"13","author":"Uher","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.beem.2024.101941_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.intimp.2016.08.004","article-title":"The use of Zymosan A and bacteria anchored to tumor cells for effective cancer immunotherapy: B16-F10 murine melanoma model","volume":"39","author":"Waldmannova","year":"2016","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.beem.2024.101941_bib9","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41467-023-36769-6","article-title":"Genomic and immune landscape of metastatic pheochromocytoma and paraganglioma","volume":"14","author":"Calsina","year":"2023","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.beem.2024.101941_bib10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.beem.2024.101941_bib11","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1038\/s41467-022-34011-3","article-title":"Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment","volume":"13","author":"Zethoven","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.beem.2024.101941_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12020-022-03218-1","article-title":"Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis","volume":"79","author":"Ghosal","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2024.101941_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202000044","article-title":"Induction of immune response against metastatic tumors via vaccination of Mannan-BAM, TLR ligands, and anti-CD40 antibody (MBTA)","author":"Medina","year":"2020","journal-title":"Adv Ther-Ger"},{"issue":"71","key":"10.1016\/j.beem.2024.101941_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn5859","article-title":"Intratumoral immunotherapy relies on B and T cell collaboration","volume":"7","author":"Sagiv-Barfi","year":"2022","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.beem.2024.101941_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40425-019-0613-1","article-title":"B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors","volume":"7","author":"Damsky","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.beem.2024.101941_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69713","article-title":"Redefining innate natural antibodies as important contributors to anti-tumor immunity","volume":"10","author":"Rawat","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.beem.2024.101941_bib17","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.3389\/fimmu.2018.01894","article-title":"Ranitidine inhibition of breast tumor growth is B cell dependent and associated with an enhanced antitumor antibody response","volume":"9","author":"Rogers","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.beem.2024.101941_bib18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ijc.21177","article-title":"Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells","volume":"117","author":"Shah","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beem.2024.101941_bib19","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3389\/fimmu.2017.01548","article-title":"Unconventional pro-inflammatory CD4(+) T cell response in B cell-deficient mice infected with Trypanosoma cruzi","volume":"8","author":"Gorosito Serran","year":"2017","journal-title":"Front Immunol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T16:50:57Z","timestamp":1738342257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X24001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1521690X24001179"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2024.101941","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of B cells in intratumoral MBTA immunotherapy of murine pheochromocytoma model","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2024.101941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101941"}}